Reccurent thrombus in the gigantic left atrium during effective anticoagulant therapy: case report
Jazyk angličtina Země Velká Británie, Anglie Médium electronic
Typ dokumentu kazuistiky, práce podpořená grantem, časopisecké články
Grantová podpora
LQ1605 - National Program of Sustainability II (MEYS CR)
Ministerstvo Školství, Mládeže a Tělovýchovy (CZ) - International
PubMed
32085730
PubMed Central
PMC7035782
DOI
10.1186/s12872-019-01279-1
PII: 10.1186/s12872-019-01279-1
Knihovny.cz E-zdroje
- Klíčová slova
- Anticoagulant therapy, Atrial fibrillation, Cardiac magnetic resonance, Echocardiography, Gigantic left atrium, Recurrent thrombus,
- MeSH
- anuloplastika mitrální chlopně škodlivé účinky MeSH
- chirurgická náhrada chlopně škodlivé účinky MeSH
- inhibitory agregace trombocytů aplikace a dávkování MeSH
- inhibitory faktoru Xa aplikace a dávkování MeSH
- klopidogrel aplikace a dávkování MeSH
- kombinovaná farmakoterapie MeSH
- lidé MeSH
- mitrální insuficience diagnostické zobrazování chirurgie MeSH
- nemoci srdce diagnostické zobrazování farmakoterapie etiologie chirurgie MeSH
- recidiva MeSH
- rivaroxaban aplikace a dávkování MeSH
- senioři MeSH
- srdeční síně diagnostické zobrazování účinky léků chirurgie MeSH
- trombektomie MeSH
- trombóza diagnostické zobrazování farmakoterapie etiologie chirurgie MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- práce podpořená grantem MeSH
- Názvy látek
- inhibitory agregace trombocytů MeSH
- inhibitory faktoru Xa MeSH
- klopidogrel MeSH
- rivaroxaban MeSH
BACKGROUND: Gigantic left atrium is defined in the current literature as an excessive dilatation of the left atrium above 65mm. Chronic mitral valve disease is associated with the development of thrombus in the left atrium in up to 19% of all cases of mitral insufficiency and appropriate treatment must be initiated to prevent thromboembolic events. In order to diagnose thrombi in the left atrium or left atrial appendage, various imaging methods may be used, including cardiac magnetic resonance. CASE PRESENTATION: The case report describes a 73-year-old male who developed recurrent sessile thrombus on the posterior wall of the gigantic left atrium. A large thrombus was first detected following mitral valve surgery despite effective vitamin K antagonist anticoagulation therapy. Echocardiography and cardiac magnetic resonance were used within the diagnostic procedure and to monitor the treatment outcomes. Cardiac magnetic resonance was shown to be beneficial as it provided a more precise description of the intra-atrial masses located on the posterior left atrial wall, and in such situations, is of greater benefit than standard echocardiography. This led to the surgical removal of the intra-atrial mass; nevertheless, it was quickly followed by the recurrence of the thrombus. The anticoagulant therapy was adjusted and fortified by the introduction of acetylsalicylic acid and sequentially clopidogrel, but this also did not resolve the thrombus formation. Finally, employing a combination of rivaroxaban and clopidogrel resulted in partial thrombus regression. Therefore, various pathophysiological aspects of thrombus formation and used anticoagulation strategies are discussed. CONCLUSIONS: We describe a unique case of a recurrent thrombus located on the posterior wall of the gigantic left atrium. Cardiac magnetic resonance was shown to be beneficial in providing a more precise description of the intra-atrial masses located on the posterior left atrial wall as compared to standard echocardiographic examination. Development of a thrombus after mitral valve surgery despite effective anticoagulant therapy and its final resolution by introducing a combination of rivaroxaban and clopidogrel highlights the complex etiopathogenesis of thrombus formation. This supports the potential use of this combination in tailoring an individual personalized therapy for patients with recurrent atrial thrombi.
Center for Cardiovascular Surgery and Organ Transplantation Brno Czech Republic
Department of Biology Faculty of Medicine Masaryk University Brno Czech Republic
Department of Physiology Faculty of Medicine Masaryk University Brno Czech Republic
Department of Radiology St Anne's University Hospital and Masaryk University Brno Czech Republic
International Clinical Research Center St Anne's University Hospital Brno Czech Republic
Zobrazit více v PubMed
PLASCHKES J., BORMAN J. B., MERIN G., MILWIDSKY H. Giant Left Atrium in Rheumatic Heart Disease. Annals of Surgery. 1971;174(2):194–201. doi: 10.1097/00000658-197108000-00004. PubMed DOI PMC
Piccoli GP, Massini C, Di Eusanio G, Ballerini L, Iacobone G, Soro A, et al. Giant left atrium and mitral valve disease: early and late results of surgical treatment in 40 cases. J Cardiovasc Surg (Torino). 1984;25(4):328–36. PubMed
Sanfilippo A J, Abascal V M, Sheehan M, Oertel L B, Harrigan P, Hughes R A, Weyman A E. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation. 1990;82(3):792–797. doi: 10.1161/01.CIR.82.3.792. PubMed DOI
Can Mehmet Mustafa, Tanboğa İbrahim Halil, Demircan Hacer Ceren, Özkan Alper, Koca Fatih, Keleş Nurşen, Sönmez Kenan, Kaymaz Cihangir, Serebruany Victor. Acute Kidney Infarction Secondary to Intracardiac Thrombus Embolization in a Patient with Ischemic Dilated Cardiomyopathy. Cardiology. 2010;117(3):219–221. doi: 10.1159/000322510. PubMed DOI
Ates M, Sensoz Y, Abay G, Akcar M. Giant left atrium with rheumatic mitral stenosis. Tex Heart Inst J. 2006;33(3):389–91. PubMed PMC
Kaymaz C. Location, Size and Morphological Characteristics of Left Atrial Thrombi as Assessed by Echocardiography in Patients with Rheumatic Mitral Valve Disease. European Journal of Echocardiography. 2001;2(4):270–276. doi: 10.1053/euje.2001.0093. PubMed DOI
Tewari P, Dixit A, Soori R. Unknown Left Atrial Appendage Mass! Real-time Three-dimensional Transesophageal Echocardiography Helps in Identification. Ann Card Anaesth. 2018;21(1):97–8. PubMed PMC
Chen J., Zhang H., Zhu D., Wang Y., Byanju S., Liao M. Cardiac MRI for detecting left atrial/left atrial appendage thrombus in patients with atrial fibrillation. Herz. 2018;44(5):390–397. doi: 10.1007/s00059-017-4676-9. PubMed DOI
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–962. PubMed
Niemann Markus, Gaudron Philipp Daniel, Bijnens Bart, Störk Stefan, Beer Meinrad, Hillenbrand Hanns, Cikes Maja, Herrmann Sebastian, Hu Kai, Ertl Georg, Weidemann Frank. Differentiation Between Fresh and Old Left Ventricular Thrombi by Deformation Imaging. Circulation: Cardiovascular Imaging. 2012;5(5):667–675. PubMed
Ito T, Suwa M, Nakamura T, Miyazaki S, Kobashi A, Kitaura Y. Quantification of left atrial appendage spontaneous echo contrast in patients with chronic nonalvular atrial fibrillation. J Cardiol. 2001;37(6):325–33. PubMed
Larsson MK, Da Silva C, Gunyeli E, Ilami AAB, Szummer K, Winter R, et al. The potential clinical value of contrast-enhanced echocardiography beyond current recommendations. Cardiovasc Ultrasound. 2016;14:2. PubMed PMC
Marsico Fabio, Cecere Milena, Parente Antonio, Paolillo Stefania, de Martino Fabiana, Dellegrottaglie Santo, Trimarco Bruno, Perrone Filardi Pasquale. Effects of novel oral anticoagulants on left atrial and left atrial appendage thrombi: an appraisal. Journal of Thrombosis and Thrombolysis. 2016;43(2):139–148. doi: 10.1007/s11239-016-1421-9. PubMed DOI
Park Hanbit, Jo Seokjung, Cho Yun Kyung, Kim Jongkwan, Cho Sangcheol, Kim Ju Hyeon, Jeong Yeong jin, Song Jae-Kwan. Differential Diagnosis of a Left Atrial Mass after Surgical Excision of Myxoma: a Remnant or a Thrombus? Korean Circulation Journal. 2016;46(6):875. doi: 10.4070/kcj.2016.46.6.875. PubMed DOI PMC
Silaruks Songkwan, Thinkhamrop Bandit, Kiatchoosakun Songsak, Wongvipaporn Chaiyasith, Tatsanavivat Pyatat. Resolution of Left Atrial Thrombus after 6 Months of Anticoagulation in Candidates for Percutaneous Transvenous Mitral Commissurotomy. Annals of Internal Medicine. 2004;140(2):101. doi: 10.7326/0003-4819-140-2-200401200-00010. PubMed DOI
Kuroda Yuki, Minakata Kenji, Yamazaki Kazuhiro, Sakaguchi Hisashi, Uehara Kyokun, Sakata Ryuzo. A Giant Left Atrial Thrombus After Radiofrequency Catheter Ablation. The Annals of Thoracic Surgery. 2016;102(5):e461. doi: 10.1016/j.athoracsur.2016.05.022. PubMed DOI
Saito Shin, Tomita Hirofumi, Kimura Yoshihiro, Shiroto Hiroshi, Hagii Joji, Metoki Norifumi, Hitomi Hiroyasu, Kamada Takaatsu, Osanai Tomohiro, Okumura Ken, Yasujima Minoru. Reduced Smoke-like Echo and Resolved Thrombus in the Left Atrium with Rivaroxaban Therapy in an Acute Cardioembolic Stroke Patient. Journal of Stroke and Cerebrovascular Diseases. 2014;23(6):1747–1749. doi: 10.1016/j.jstrokecerebrovasdis.2014.01.014. PubMed DOI
Scarano M, Casale M, Mantini C, Imbalzano E, Consorti C, Clemente D, et al. Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report. J Med Case Reports. 2017;11(1):97. PubMed PMC
Potpara Tatjana S., Lip Gregory Y.H. Oral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk. Progress in Cardiovascular Diseases. 2015;58(2):177–194. doi: 10.1016/j.pcad.2015.07.003. PubMed DOI